374 related articles for article (PubMed ID: 32046979)
1. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.
Rees M; Angioli R; Coleman RL; Glasspool RM; Plotti F; Simoncini T; Terranova C
Int J Gynecol Cancer; 2020 Apr; 30(4):428-433. PubMed ID: 32046979
[TBL] [Abstract][Full Text] [Related]
2. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.
Rees M; Angioli R; Coleman RL; Glasspool R; Plotti F; Simoncini T; Terranova C
Maturitas; 2020 Apr; 134():56-61. PubMed ID: 32059825
[TBL] [Abstract][Full Text] [Related]
3. Management of menopausal symptoms and ovarian function preservation in women with gynecological cancer.
Brennan A; Brennan D; Rees M; Hickey M
Int J Gynecol Cancer; 2021 Mar; 31(3):352-359. PubMed ID: 33127864
[TBL] [Abstract][Full Text] [Related]
4. Estrogen therapy in gynecological cancer survivors.
Guidozzi F
Climacteric; 2013 Dec; 16(6):611-7. PubMed ID: 23952524
[TBL] [Abstract][Full Text] [Related]
5. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
6. The 2017 hormone therapy position statement of The North American Menopause Society.
The NAMS 2017 Hormone Therapy Position Statement Advisory Panel
Menopause; 2017 Jul; 24(7):728-753. PubMed ID: 28650869
[TBL] [Abstract][Full Text] [Related]
7. The 2017 hormone therapy position statement of The North American Menopause Society.
Menopause; 2018 Nov; 25(11):1362-1387. PubMed ID: 30358733
[TBL] [Abstract][Full Text] [Related]
8. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
10. Undertreatment of menopausal symptoms and novel options for comprehensive management.
Lewis V
Curr Med Res Opin; 2009 Nov; 25(11):2689-98. PubMed ID: 19775194
[TBL] [Abstract][Full Text] [Related]
11. Management of menopausal symptoms in women with gynecologic cancers.
Del Carmen MG; Rice LW
Gynecol Oncol; 2017 Aug; 146(2):427-435. PubMed ID: 28625396
[TBL] [Abstract][Full Text] [Related]
12. Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society.
Lambrinoudaki I; Armeni E; Goulis D; Bretz S; Ceausu I; Durmusoglu F; Erkkola R; Fistonic I; Gambacciani M; Geukes M; Hamoda H; Hartley C; Hirschberg AL; Meczekalski B; Mendoza N; Mueck A; Smetnik A; Stute P; van Trotsenburg M; Rees M
Maturitas; 2022 Sep; 163():1-14. PubMed ID: 35569270
[TBL] [Abstract][Full Text] [Related]
13. No. 385-Indications for Pelvic Examination.
Evans D; Goldstein S; Loewy A; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
[TBL] [Abstract][Full Text] [Related]
14. Global consensus statement on menopausal hormone therapy.
de Villiers TJ; Gass ML; Haines CJ; Hall JE; Lobo RA; Pierroz DD; Rees M
Climacteric; 2013 Apr; 16(2):203-4. PubMed ID: 23488524
[TBL] [Abstract][Full Text] [Related]
15. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
16. [Prevention and treatment of postmenopausal osteoporosis in women treated for cancer].
Pratili MA; Gest-Laval C
Bull Cancer; 1992; 79(7):651-7. PubMed ID: 1467591
[TBL] [Abstract][Full Text] [Related]
17. [How to diagnose menopause? Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
Rousset-Jablonski C
Gynecol Obstet Fertil Senol; 2021 May; 49(5):318-328. PubMed ID: 33867317
[TBL] [Abstract][Full Text] [Related]
18. Hormonal management of menopausal symptoms in women with a history of gynecologic malignancy.
Harris BS; Bishop KC; Kuller JA; Ford AC; Muasher LC; Cantrell SE; Price TM
Menopause; 2020 Feb; 27(2):243-248. PubMed ID: 31738735
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.
Stuenkel CA; Davis SR; Gompel A; Lumsden MA; Murad MH; Pinkerton JV; Santen RJ
J Clin Endocrinol Metab; 2015 Nov; 100(11):3975-4011. PubMed ID: 26444994
[TBL] [Abstract][Full Text] [Related]
20. Demographic characteristics and medical aspects of menopausal women in Taiwan.
Chow SN; Huang CC; Lee YT
J Formos Med Assoc; 1997 Oct; 96(10):806-11. PubMed ID: 9343980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
